Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine

Clinical trial NCT01357915 · COMPLETED

Trial details

NCT number: NCT01357915
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Infections, Cytomegalovirus

Start date: 2011-06-24
Primary completion: 2012-09-13
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.